Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Benefit of Ambroxol on Parkison Disease Dementia Unclear
HER2DX Adds Prognostic Precision in Early HER2+ Breast Cancer
Overview of Cytomegalovirus Colitis in Adults with Inflammatory Bowel Disease